Desferrioxamine related maculopathy: A case report

被引:14
作者
Arora, A
Wren, S
Evans, KG
机构
[1] Univ London Imperial Coll Sci Technol & Med, Sch Med, Charing Cross Hosp, Dept Acad Ophthalmol, London, England
[2] Western Eye Hosp, London, England
关键词
desferrioxamine; screening; maculopathy;
D O I
10.1002/ajh.20090
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Desferrioxamine is used for the treatment of chronic iron overload, acute iron poisoning, and certain anaemias. Ocular toxicity secondary to prolonged treatment with desferrioxamine may result in night blindness, visual field constriction, cataract, pigmentary retinopathy and optic neuropathy. To avoid such complications an ophthalmic screening has been suggested for patients taking desferrioxamine. We report an 81-year-old patient who developed irreversible ocular toxicity despite undergoing ophthalmic screening. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:386 / 388
页数:3
相关论文
共 15 条
[1]   OCULAR CHANGES IN PATIENTS UNDERGOING LONG-TERM DESFERRIOXAMINE TREATMENT [J].
ARDEN, GB ;
WONKE, B ;
KENNEDY, C ;
HUEHNS, ER .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1984, 68 (12) :873-877
[2]   Bull's eye maculopathy with deferoxamine [J].
Bansal, V ;
Elgarbly, I ;
Ghanchi, FD ;
Atkinson, PL .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 70 (06) :420-421
[3]   DISTRIBUTION OF COPPER AND ZINC IN MAMMALIAN EYES - OCCURRENCE OF METALS IN MELANIN FRACTIONS FROM EYE TISSUES [J].
BOWNESS, JM ;
MORTON, RA ;
SHAKIR, MH ;
STUBBS, AL .
BIOCHEMICAL JOURNAL, 1952, 51 (04) :521-530
[4]   Iron Chelators for the treatment of iron overload disease: Relationship between structure, redox activity, and toxicity [J].
Chaston, TB ;
Richardson, DR .
AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (03) :200-210
[5]  
DAVIES SC, 1983, LANCET, V2, P181
[6]  
DONCKER RDE, 1987, B SOC BELG OPHTHALM, V220, P61
[7]   The expanded clinical spectrum of deferoxamine retinopathy [J].
Haimovici, R ;
D'Amico, DJ ;
Gragoudas, ES ;
Sokol, S .
OPHTHALMOLOGY, 2002, 109 (01) :164-171
[8]  
HALL P, 1989, BR J OPHTHALMOL, V73, P42
[9]   Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1) [J].
Kontoghiorghes, GJ ;
Pattichi, K ;
Hadjigavriel, M ;
Kolnagou, A .
TRANSFUSION SCIENCE, 2000, 23 (03) :211-223
[10]  
MARMOR MF, 1989, ARCH OPHTHALMOL-CHIC, V107, P816, DOI 10.1007/BF00154486